EDUCATION

1997/3-2001/2 Seoul National University, B.S. in Chemistry

2001/3-2003/2 Seoul National University, M.S. in Chemistry

2004/9-2008/11 Princeton University, Ph.D. in Chemistry

AREAS OF RESEARCH

   Synthetic organic chemistry: Heterocyclic synthesis, development of selective C-H bond functionalization reactions, and application to drug discovery and materials science

EXPERIENCES

2003/8-2004/7 Seoul National University, Department of chemistry, Full-time Teaching Assistant

2008/11-2011/4 Columbia University, Department of Chemistry, Postdoctoral Research Scientist

2011/5-2013/8 Eli Lilly and Company, Research Scientist  

SELECTED PUBLICATIONS  

9. “C  ?  H Bonds as Ubiquitous Functionality: Preparation of Multiple Regioisomers of Arylated 1,2,4- Triazoles via C  ?  H Arylation,” J. M. Joo, P. Guo, D. Sames, J. Org. Chem. 2013, 78, 738  ?  743.     
     
8. “C  ?  H Arylation of Pyridines: High Regioselectivity as a Consequence of the Electronic Character of C  ?  H Bonds and Heteroarene Ring,” P. Guo, J. M. Joo, S. Rakshit, D. Sames, J. Am. Chem. Soc. 2011, 133, 16338  ?  16341.     
     
7. “C  ?  H Bonds as Ubiquitous Functionality: A General Approach to Complex Arylated Imidazoles via Regioselective Sequential Arylation of All Three C  ?  H Bonds and Regioselective N  ?  alkylation Enabled by SEM  ?  group Transposition,” J. M. Joo, B. B. Tour?, and D. Sames, J. Org. Chem. 2010, 75, 4911  ?  4920.    
     
6. “Concise Synthesis of the Erythrina Alkaloid 3  ?  Demethoxyerythratidinone via Combined Rhodium Catalysis,” J. M. Joo, R. A. David, Y. Yuan, and C. Lee, Org. Lett. 2010, 12, 5704  ?  5707.     
     
5. “Tandem Cyclization of Alkynes via Rhodium Alkynyl and Alkenylidene Catalysis,” J. M. Joo, Y. Yuan, C. Lee, J. Am. Chem. Soc. 2006, 128, 14818  ?  14819.     
     
4. “Synthesis and Evaluation of Lasonolide A Analogues,” J. M. Joo, H. S. Kwak, J. H. Park, H. Y. Song, E. Lee, Bioorg. Med. Chem. Lett. 2004, 14, 1905  ?  1908.     
     
3. “Lasonolide A: Structural Revision and Total Synthesis,” H. Y. Song, J. M. Joo, J. W. Kang, D.-S. Kim, C.-K. Jung, H. S. Kwak, J. H. Park, E. Lee, C. Y. Hong, S. Jeong, K. Jeon, J. H. Park, J. Org. Chem. 2003, 68, 8080  ?  8087.     
     
2. “Synthesis of (+)-Lasonolide A: (  ?  )-Lasonolide A is the Biologically Active Enantiomer,” E. Lee, H. Y. Song, J. M. Joo, J. W. Kang, D. S. Kim, C. K. Jung, C. Y. Hong, S. Jeong, K. Jeon, Bioorg. Med. Chem. Lett. 2002, 12, 3519  ?  3520.   
     
1. “Lasonolide A: Structural Revision and Synthesis of the Unnatural (  ?  )-Enantiomer,” E. Lee, H. Y. Song, J. W. Kang, D.-S. Kim, C.-K. Jung, J. M. Joo, J. Am. Chem. Soc. 2002, 124, 384  ?  385.